Target Discovery

News

JPM: Illumina launches 'unprecedented' disease biology atlas

Illumina says its new Billion Cell Atlas can be used to identify and validate drug targets and train AI models used in drug discovery.

News

Lab-in-a-loop specialist Relation attracts Novartis alliance

UK-based AI and multi-omics company Relation Therapeutics will seek out targets for allergic diseases on behalf of Novartis in a $1.7bn-plus alliance.

News

AstraZeneca joins Tempus, Pathos in cancer AI project

AstraZeneca has started work with Tempus and Pathos AI on a $200m project to build a comprehensive multimodal foundation model for oncology.

News

CRUK scientists find new tool to test lung cancer therapies

Researchers in the UK have developed a lung cancer cell line that they believe could be an important new tool for the discovery of new therapies.

News

World's largest proteomics trial launched by UK Biobank

A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today.

News

AI firm Generate signs $1bn discovery deal with Novartis

Flagship Pioneering-backed artificial intelligence start-up Generate:Biomedicines has attracted another big pharma partnership, this time with Novartis.

JPM: Illumina launches 'unprecedented' disease biology atlas

Lab-in-a-loop specialist Relation attracts Novartis alliance

AstraZeneca joins Tempus, Pathos in cancer AI project

CRUK scientists find new tool to test lung cancer therapies

World's largest proteomics trial launched by UK Biobank

AI firm Generate signs $1bn discovery deal with Novartis

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

Target Discovery

Editor's Picks